Sign In
Buy DMTK
$0.0940
+0 (+0%)
At Close: Oct 21, 2024
DermTech's (DMTK) CEO John Dobak on Q4 2020 Results - Earnings Call Transcript
10:14pm, Thursday, 04'th Mar 2021
DermTech's (DMTK) CEO John Dobak on Q4 2020 Results - Earnings Call Transcript
DermTech, Inc. (DMTK) Reports Q4 Loss, Tops Revenue Estimates
08:28pm, Thursday, 04'th Mar 2021
DermTech, Inc. (DMTK) delivered earnings and revenue surprises of 11.11% and 24.77%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Why DermTech Stock Is a Buy Right Now
06:12am, Wednesday, 24'th Feb 2021
This high-flying healthcare stock should have more room to run.
DermTech Abstracts Selected to Present at Society of Investigative Dermatology Virtual Meeting
04:30pm, Monday, 22'nd Feb 2021
LA JOLLA, Calif.--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today that four of its
It's Already Doubled in 2021, and This Healthcare Juggernaut Is Just Getting Started
07:18am, Saturday, 20'th Feb 2021
Dermtech stock is up over 130% so far in 2021, and increased insurance acceptance is just one reason it could be a five-bagger in the next five years.
3 Top Small-Cap Stocks to Buy Right Now
06:06am, Wednesday, 17'th Feb 2021
All three companies are multi-baggers in the last year and have more room to run.
Dermtech Rallies To Record High On Health Insurance Contract For Skin Cancer Detection Test
10:25am, Thursday, 11'th Feb 2021
DermTech Inc (NASDAQ: DMTK) shares were soaring to a new high Thursday after the company unveiled a contract with Blue Cross Blue Shield of Texas for its melanoma gene express test. What Happened: La
Why DermTech Stock Gained 26% Last Month
04:48pm, Monday, 08'th Feb 2021
Investor excitement mounted around the skin-care detection specialist.
DermTech Announces New Scientific Advisory Board Members
04:30pm, Monday, 08'th Feb 2021
LA JOLLA, Calif.--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today the additions of
3 Unstoppable Stocks That'll Crush GameStop in 2021
07:00am, Sunday, 07'th Feb 2021
They don't need a short squeeze to skyrocket.
DermTech Management to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
04:01pm, Wednesday, 03'rd Feb 2021
LA JOLLA, Calif.--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today that DermTech man
Got $2,000? Here Are 3 Top Growth Stocks to Buy in February
06:01am, Wednesday, 03'rd Feb 2021
The shortest month is a great time to go long with these great stocks.
DermTech Featured in Melanoma Research Foundation Weekly “Ask the Expert” Facebook Live Events Alongside Notable Industry Scientists
04:30pm, Thursday, 28'th Jan 2021
LA JOLLA, Calif.--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today its support and p
DermTech Chief Scientific Officer Michael Howell Presented at Dermatology Summit 2021
04:30pm, Tuesday, 19'th Jan 2021
LA JOLLA, Calif.--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today its presentation
These 3 Under-the-Radar Stocks Are Great Buys Right Now
06:02am, Monday, 18'th Jan 2021
You might not hear much about them, but that could be a good thing.
